Home › Funds › ADAR1 Capital Management, LLC › VKTX
ADAR1 Capital Management, LLC position in VKTX
VIKING THERAPEUTICS INC · Health Care
ADAR1 Capital Management, LLC reported holding 100,000 shares of VKTX (VIKING THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.0M, representing 0.55% of its reported portfolio and ranking #50 among its reported holdings. ADAR1 Capital Management, LLC has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's VKTX position evolved
ADAR1 Capital Management, LLC first disclosed a stake in VKTX in Q4 2023 at 254,151 shares (US$4.7M). The position peaked in Q2 2026 at 574,038 shares, worth US$22.4M. Across 12 filings, ADAR1 Capital Management, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 100,000 shares valued at US$10.0M — a reduction of -474,038 shares quarter over quarter.. Notable position changes include a 533% increase in Q2 2024 (shares rose 19% over the following quarter), a 539% increase in Q1 2025 (shares rose 10% over the following quarter), a 760% increase in Q1 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 254.15K | $4.73M | New |
| Q1 2024 | 14.40K | $1.18M | Reduce |
| Q2 2024 | 91.23K | $4.84M | Add |
| Q3 2024 | 7.10K | $449.50K | Reduce |
| Q4 2024 | 9.30K | $374.23K | Add |
| Q1 2025 | 59.41K | $1.43M | Add |
| Q2 2025 | 67.81K | $1.80M | Add |
| Q3 2025 | 175.92K | $4.62M | Add |
| Q4 2025 | 26.49K | $932.06K | Reduce |
| Q1 2026 | 227.72K | $7.41M | Add |
| Q2 2026 | 574.04K | $22.39M | Add |
| Q3 2026 | 100.00K | $9.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VKTX and 13F data
VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 28 other funds we track also report a position in VKTX — the largest reported positions include Context Capital Management, LLC (US$39.9M), Eversept Partners, LP (US$32.8M), Vestal Point Capital, LP (US$26.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VKTX
- Context Capital Management, LLC 40.00M sh · $39.91M · Q3 2026
- Eversept Partners, LP 1.01M sh · $32.81M · Q3 2026
- Vestal Point Capital, LP 680.00K sh · $26.53M · Q2 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held VKTX?
ADAR1 Capital Management, LLC has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is ADAR1 Capital Management, LLC's current position in VKTX?
As of Q3 2026, ADAR1 Capital Management, LLC holds 100.00K shares of VKTX (VIKING THERAPEUTICS INC), valued at $9.95M, representing 0.55% of its reported portfolio and ranking #50.
Has ADAR1 Capital Management, LLC been buying or selling VKTX?
In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC reduced its position in VKTX. The position peaked in Q2 2026 at 574.04K shares.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Context Capital Management, LLC, Eversept Partners, LP, Vestal Point Capital, LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.